Pandion Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2020 to a ratio of 5.01, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2020. Average collection period, for Pandion Therapeutics Inc 's accounts receivable remained unchanged at 73 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector Pandion Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Pandion Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PAND Receivables Turnover Ratio	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) II. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	126.58 %	-	-	-	-
Receivable Turnover Ratio (TTM)	5.01	4.98	4.97	3.74	-
PAND's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	73	73	73	98	-
Seq. Receivable Change	-54.93 %	59.94 %	27.34 %	-	-
Seq. Revenue Change	-16.76 %	34.63 %	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

PAND Company Profile • Back to PAND Efficiency Comparisons • Compare PAND Receivables Turnover Ratio to its Competitors

Financial Statements
Pandion Therapeutics Inc 's Accounts Receivable	$ 1 Millions	Visit PAND's Balance sheet
Pandion Therapeutics Inc 's Sales TTM	$ 7 Millions	Visit PAND's Income Statement
Sources of PAND's Revenues		Visit PAND's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PAND's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PAND's Growth Rates	PAND's Roa	PAND's Inventory Turnover Ratio	PAND's Dividend Comparisons
PAND's Profitability Ratios	PAND's Roi	PAND's Asset Turnover Ratio	PAND's Dividend Growth
PAND's Valuation Ratios	PAND's Roe	PAND's Financial Strength Ratios	PAND's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2020	Receivable at quarter ending Dec 31 2020
Fonar Corporation	19.49	$ 78.814 Millions	$ 4.043 Millions
Therapeutic Solutions International Inc	19.46	$ 0.063 Millions	$ 0.003 Millions
China Pharma Holdings Inc	19.37	$ 10.866 Millions	$ 0.561 Millions
Xenon Pharmaceuticals Inc	18.83	$ 32.166 Millions	$ 1.709 Millions
Cv Sciences Inc	18.81	$ 24.429 Millions	$ 1.299 Millions
Catalyst Pharmaceuticals Inc	18.65	$ 119.073 Millions	$ 6.385 Millions
Ascendis Pharma A	17.97	$ 7.787 Millions	$ 0.433 Millions
Ibio inc	17.76	$ 2.331 Millions	$ 0.131 Millions
Fulcrum Therapeutics Inc	17.65	$ 8.823 Millions	$ 0.500 Millions
Emmaus Life Sciences Inc	17.55	$ 23.167 Millions	$ 1.320 Millions
Delcath Systems Inc	17.51	$ 1.646 Millions	$ 0.094 Millions
Semler Scientific inc	17.50	$ 38.603 Millions	$ 2.207 Millions
Neurometrix Inc	16.76	$ 7.378 Millions	$ 0.440 Millions
Electrocore Inc	16.69	$ 3.496 Millions	$ 0.210 Millions
Chemed Corporation	16.48	$ 2,079.583 Millions	$ 126.218 Millions
Myomo Inc	16.46	$ 7.583 Millions	$ 0.461 Millions
Vbi Vaccines Inc	16.32	$ 1.061 Millions	$ 0.065 Millions
Rafael Holdings Inc	16.22	$ 4.476 Millions	$ 0.276 Millions
Agenus Inc	16.15	$ 88.170 Millions	$ 5.461 Millions
Avita Medical Inc	15.98	$ 17.917 Millions	$ 1.121 Millions
Cytokinetics Incorporated	15.57	$ 55.828 Millions	$ 3.586 Millions
Mannkind Corporation	15.56	$ 65.144 Millions	$ 4.188 Millions
Petvivo Holdings Inc	15.43	$ 0.024 Millions	$ 0.002 Millions
Skinvisible Inc	15.42	$ 0.160 Millions	$ 0.010 Millions
Rockwell Medical inc	15.12	$ 62.197 Millions	$ 4.113 Millions
Dariohealth Corp	14.68	$ 7.576 Millions	$ 0.516 Millions
Corcept Therapeutics Inc	14.51	$ 353.874 Millions	$ 24.391 Millions
Revance Therapeutics Inc	13.74	$ 15.325 Millions	$ 1.116 Millions
Dmk Pharmaceuticals Corporation	13.70	$ 13.095 Millions	$ 0.956 Millions
Personalis Inc	13.60	$ 78.648 Millions	$ 5.784 Millions

Date modified: 2026-09-08T15:10:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.